...GlaxoSmithKline Plc, talks with Bloomberg's Francine Lacqua from London about first-quarter earnings, the company's drugs Avandia, Tykerb and Cervarix, and Glaxo's acquisition of Sirtris ...
7 months ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
...GlaxoSmithKline Plc, talks with Bloomberg's Nina de Roy and Rishaad Salamat from Middlesex, England, about the safety of diabetes drug Avandia, the outlook for new products and second-quarter ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
...GlaxoSmithKline Plc, talks with Bloomberg's Ellen Braitman from Washington about the safety of the company's Avandia diabetes drug. Glaxo representatives and officials of the U.S. Food and Drug ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
...GlaxoSmithKline ...sible strategy under chief executive officer-designate Andrew Witty, who will succeed CEO Jean-Pierre Garnier in May. GlaxoSmithKline is Europe's largest drugmaker. (Source: ...
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to:
Jean-Pierre Garnier, chief executive officer of GlaxoSmithKline Plc, talks with Bloomberg's Deborah Kostroun from New York about the company's drug development, investment in research and development, and the Excellence in Corporate Philanthropy Award the company received today. (Source: Bloomberg)
a year ago
Bloomberg - Financial News
Keep this video in the "Saved" list
Now, put vTap to work for you!
Let us keep you up to date with new videos related to: